DiscoverThe Vox Markets Podcast2008: hVIVO Year in Review: Milestones, Growth and 2025 Ambitions
2008: hVIVO Year in Review: Milestones, Growth and 2025 Ambitions

2008: hVIVO Year in Review: Milestones, Growth and 2025 Ambitions

Update: 2024-12-20
Share

Description

In our recent interview with Mo Khan, CEO of hVIVO, we reflected on the company’s outstanding achievements in 2024 and gained insights into its ambitious roadmap for 2025. Under Mo’s leadership, hVIVO has solidified its position as a global leader in human challenge trials, achieving record revenues, expanding its client base, and leveraging its cutting-edge clinical trial models to accelerate drug and vaccine development.
Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

2008: hVIVO Year in Review: Milestones, Growth and 2025 Ambitions

2008: hVIVO Year in Review: Milestones, Growth and 2025 Ambitions

Vox Markets Podcast